Paul Pavlou has been named as the dean of C. T. Bauer College of Business at the University of Houston. Courtesy of UH

Earlier this year, the University of Houston named a new dean for its C.T. Bauer College of Business. Paul Pavlou officially started his position on July 1, and, even though he has only a few days under his belt at UH, the new dean has a long career in education.

Most recently, Pavlou served as senior associate dean at Temple University within its business program and specializing in data analytics for business. Pavlou also has ties to Houston, as he received his bachelor's from Rice University after receiving a Fulbright Scholarship.

"My life was transformed by higher education," Pavlou says. "So, I feel the need to give back in terms of helping other students — especially of modest means like myself to do well in life and get a good job."

Pavlou has a lot on his plate entering the fall semester. He plans to continue enhancing the college's programs and faculty, while also continue the school's effort to bring in innovation and industry.

The new dean spoke with InnovationMap about what all he sees in Bauer's future.

InnovationMap: How has the first few days on the job been?

Paul Pavlou: So far it's been very exciting. There's so many opportunities for the Bauer College in innovation and technology in new areas that we're considering such health care, analytics, some of the existing areas in energy. So, the goal in my first few days is to talk to as many stakeholders as possible. Try to get to know our existing practices internally, what the opportunities are in the city, and of course, broadly, nationally, internationally. And accordingly, the plan is to see how we can focus on this needs of the industry, how we can create cutting edge programs and prepare the next generation of the workforce, obviously for the city of Houston or the state of Texas nationally and even that globally.

IM: What are some things on your plate that you hope to bring to the college?

PP: In general, one of the areas that I'd like to see us moving into as a college is the digital learning online and how we can do that in a way that it's convenient and flexible for students. Also at the same time, not only maintain the quality of traditional instruction, but also using technology intelligently to provide an even higher quality, more interactive experience for students.

The second thing that I'm very passionate about as well as the notion of experiential learning. I think students should learn from experience and learn by doing. So I would like to see how we can improve this at this college. I'm very happy to report that Bauer has very strong connections to industry, but I would like to make it an even a very strong proposition for the entire college — making sure that, you know, different courses that have an experiential component such as project or working closely with industry.

IM: How is Bauer focusing on the needs the city has for an emerging workforce?

PP: I think increasingly I find and identify more of the city's needs, but I think one of them is the idea of the analytics space and how to use the data. And that's across the board. I talk to people in health care and they say that health care analytics and using data in hospitals is a very important aspect.

More broadly, cutting edge technology is something that is very important not only the city of Houston but beyond. So. we're discussing this idea of artificial intelligence, and how we can play a role in this in a very important emerging area.

One of the things that I would like to see more of is for the University of Houston to work more closely with the business community. We're trying to develop partnerships with the greater Houston partnership and to see what they need as an industry, perhaps for the next generation of workforce.

IM: What role do you see the school playing in the city's innovation ecosystem?

PP: I think we can play a multiple roles. We're an educational organization, so we train the students. We want make sure that through our degrees and offerings have executive programs, and that we satisfy the need for competence and skills needed. And that's why I want us to be on the cutting edge, not only now but in the next five or 10 years.

Second, through our research and through our connections to industry, I want us to be cutting edge in terms of projects and basic research we can actually provide, whether it's analytics, artificial intelligence, or energy. Through our centers and our research, we have world class research faculty in the college. I want us to be out there and to start with the major challenges and help them.

IM: How is the college working with other programs within the university?

PP: One thing I'd like to specify, is that Bauer is obviously a college of business, but I want to take a very broad, multidisciplinary perspective and be very collaborative with the college of medicine, engineering, and nursing. And the idea is to be more open in terms of partnerships with different areas that innovation and new ideas may come into play and provide the business and entrepreneurship components to bring these ideas to market.

------

Portions of this interview have been edited.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”